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Paw edemaThe inﬂammation process is a coordinated response of the organism related to immune response with release of
pro-inﬂammatory substances, as nitric oxide, TNF-α and IL-1β. In this work, a series of lipophilic amino alcohols
were evaluated on RAW264.7 and primarymacrophages for themodulation of nitric oxide and TNF-α. The most
potent compounds were submitted to the treatment of BALB/c mice and evaluation of the carrageenan-induced
paw edema and TNF-α and IL1-β release in the paws and anti-OVA delayed type hypersensitivity reaction.
RAW264.7 and primary macrophages were incubated in the presence of amino alcohols at different concentra-
tions (1, 0.5, 0.05 and 0.005 μg mL−1). All tested compounds were not cytotoxic, however the inhibition of NO
and TNF-α were observed only in RAW264.7 cultures. The NO production were reduced in 100% for all com-
pounds, but only the compounds 4a and 4b expressively reduced the TNF-α release (67% and 92% respectively).
On the carrageenan-induced paw edema, the compound 4b treatment showed reduction of edema, TNF-α and
IL-1β as efﬁcient as dexamethasone treatment. Meanwhile, the compound 4a treatment showed only slight re-
duction of paw edema. In the anti-OVA DTH reaction, both compounds showed reduction in the paw edema as
effective as dexamethasone. In function of the observed results in vitro and in the acute and anti-OVA inﬂamma-
tion of mice paw edema compound 4b showed promissory anti-inﬂammatory properties.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The activation of macrophages is related to the production of IL-1β,
TNF-α and nitric oxide, beingmajor role in the establishment of inﬂam-
mation [1]. Inﬂammatory processes are associated with the develop-
ment of innumerous chronic diseases, such as rheumatoid arthritis,
encephalomyelitis and inﬂammatory bowel disease [2]. Thence, the
down-modulation of the inﬂammatory mediators can be valuable to
prevent the beginning of these chronic diseases [3].
Nitric oxide (NO) is produced through the iNOS (inducible nitric
oxide synthase) activity on L-arginine in macrophages activated by
LPS and inﬂammatory cytokines like IFN-γ [4]. Activated macrophages
also produce IL-1β and TNF-α and both cytokines are involved with
the activation of endothelial cells, adhesion, rolling and extravasate of
leucocytes [5,6]. However, overproductions of these inﬂammatory me-
diators are related with extensive fever, cutaneous eruption and arthri-
tis [7,8].
The inhibition of inﬂammatorymediators and the immune response
regulation, through immunosuppression activity, has been showed asMicrobiology and Immunology,
e Fora, 36036-900, Juiz de Fora,
ghts reserved.results of amino alcohols treatment [9–11]. Recent studies showed
that in vitro treatment with lipophilic amino alcohols and their sugar
derivatives inhibited the production of NO without cytotoxicity [9,11].
Taking into consideration the promising activity of these compounds,
the aim of this study was evaluate the activity of long chains lipophilic
amino alcohols on the carrageenan-induced paw edema and anti-OVA
delayed type hypersensitivity.2. Materials and methods
2.1. Chemical compounds
The tested compounds were prepared as previously described
[11]. The synthesis of the lipophilic amino alcohols 4a, 4b, 5, 6, 9
and 10, initiated with the mesylation of alcohols 1a, 1b and 7 in pyridine
at 0 °C, leading to intermediates 2a, 2b and 8 (Scheme 1). The mesylated
compounds 2a and 2b were treated with sodium azide in DMF
(dimethylformamide) at 120 °C, leading to monoazide 3a and 3b,
which were hydrogenated giving the amino alcohols 4a and 4b. The
amino alcohols 5, 6, 9 and 10 were prepared by reaction of the interme-
diates 2 or 8 with diethanolamine or 3-amino-1-propanol, in ethanol
at reﬂux. All compounds were puriﬁed and characterized by Infrared,
1H NMR and 13C NMR spectroscopy.
Scheme 1. Preparation of lipophilic amino alcohols [11].
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RAW 264.7 cells were maintained in supplemented RPMI-1640
(2 mM L-glutamine, 100 μg mL−1 of streptomycin and penicillin and
5% fetal bovine serum) at 37 °C in a humidiﬁed atmosphere in 5% CO2.
Peritoneal macrophages of naïve mice were isolated by intraperitoneal
injection of 2.0 mL of sterile 3% thioglycollate (Sigma Chemical Co.,
Saint Louis, USA). After 3 days, micewere sacriﬁced; the peritoneal cav-
ity was rinsed with 5 mL ice-cold PBS containing 0.1% BSA and
20 μmol L−1 disodium EDTA. Cell viability, by trypan blue exclusion,
was N 95%. Cells were seeded in 96-well plates at a density of 5 × 105
cells mL−1. Cells were incubated at 37 °C in 5% CO2 in the presence
of amino alcohols at different concentrations (1, 0.5, 0.05 and
0.005 μg mL−1). After one hour of incubation, the cells were stimulated
with 10 μg mL−1 LPS (Sigma, 0111:B4 Chemical Co., St. Louis, MO) and
9 ng mL−1 IFN-γ. After 24 or 48 hours, the supernatant were collected
and frozen at -20 °C until assayed to analyze NO production (48 h) and
the enzyme-linked immunosorbent assay (ELISA) (24 h).
2.3. Cell viability —MTT assay
Cell viability was measured using the MTT test [3-(4,5-
dimethylthiazolyl-2)-2,5- diphenyltetrazolium bromide] in non-
stimulated cell cultures. After 48 hours of culture the supernatant
was removed and the cells were incubated with 100 μL of supplemented
RPMImedium and 10 μL of MTT (5 mg mL−1) for 4 h at 37 °C in 5% CO2.
The reaction was stopped by adding to each well 100 μL of an acidic
isopropanol solution (100 mL of isopropyl alcohol/0.4 mL of HCl 10 N).
Following 10 min of incubation at room temperature, the optical density
(OD) values at 570 nm were determined (Spectramax 190; Molecular
Devices, Sunnyvale, CA, USA) [12,13]. The viable cell number was
expressed as a percentage relative to control cells [14]: % viability:
100 × [1− (OD cells + compound / OD cells)].
2.4. Griess method — NO production
Supernatants from 48 h of RAW 264.7 or primary macrophages
culture were analyzed for the production of nitrites through the Griessmethod. Aliquots of supernatants were plated 1:1 with 1% of sulfanil-
amide and 0.1% of N-(1-naphthyl) ethylenediamine. The NO production
wasmeasured by comparingwith a standard curve,madewith different
concentrations of NaNO2. The reading was measured in the micro plate
reader (Spectramax 190;Molecular Devices) at 540 nmwavelength [1].
The inhibition percentagewas calculated in relation to control cell stim-
ulated (LPS and IFN-γ). The results were calculated using the formula
100 − ((x1 / x2) × 100), considering x1 and x2 the mean concentra-
tion of NO (μM) in wells with treatment (x1) and with stimulated
cells not treated (x2).
2.5. Animals
Male BALB/c mice 6–8 weeks old (n = 6 per group) were obtained
from the animal care facilities of the Federal University of Juiz de Fora
(UFJF) and maintained in micro isolator cages. All procedures were in
accordance with the principles of the Brazilian Code for the Use of
Laboratory Animals and were approved by the committee on the use
of laboratory animals from UFJF (Protocol no 019/2010, Protocol no
012/2013). The mice were monitored for clinical signs of toxicity after
the treatments.
2.6. Induction of acute response inﬂammatory by carrageenan-induced
paw edema
Initially the mice (n = 6 per group) were weighed (26.57 ± 0.3 g)
and their right and left paws were measured with a pachymeter (0 h).
Dexamethasone was used as positive control treatment due its anti-
inﬂammatory activity [15]. 30 Minutes before induction of edema in
the paw, PBS, dexamethasone (0.5 mg kg−1) or the tested amino
alcohols (0.5 mg kg−1) were administered intraperitoneally (100 μL).
Carrageenan (2.5%) was dissolved in PBS, and 20 μL injected into the
left footpad, and 20 μL of PBS into the right footpad of all groups. The
left and the right paws were measured after 1, 2, 3 and 4 h after the
injection of carrageenan and the difference were calculated. Themagni-
tude of the carrageenan-induced paw edema was determined as
follows: [Paw edema (mm)] = [footpad thickness of Carrageenan
(mm)] − [footpad thickness of PBS (mm)].
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esthesia (i.p.) and the paws were removed and weighed. The inﬂamed
footpad tissue were macerated as following procedure; one hundred
mg of tissues were homogenized in 1 mL of 0.4 M NaCl, 0.05% tween
20 (Merck & Co., Inc., Whitehouse Station, USA), containing 0.5% bovine
serum albumin (BSA), 0.1 M phenylmethylsulphonyl ﬂuoride (PMSF),
0.1 M benzethonium chloride, 10 mM ethylenediaminetetracetic acid
(EDTA) and 20 kIU mL−1 aprotinin (Sigma). The supernatants were
collected to determine the concentration of TNF-α and IL1-β.
2.7. Cytokine production
TNF-α level in the supernatants from 24 h of RAW 264.7 or primary
macrophages culture and IL1-β and TNF-α level in the supernatants of
macerated footpad tissue after induction of inﬂammation by carrageen-
an were determined by ELISA, as described by the manufacturer (BD
Biosciences, SanDiego, CA, USA). The reactionwas stoppedwith sulfuric
acid (1 mol L−1). The plates were read at 450 nm using a microplate
reader (Spectramax 190, Molecular Devices, Sunnyvale, CA, USA).
2.8. Induction of anti-OVA delayed-type hypersensitivity reaction
The DTH reaction usedOVA, a protein that can be usedwith orwith-
out adjuvant as an antigen to sensitize laboratory animals. DTH was in-
duced by immunization with OVA (Sigma). Brieﬂy, mice (n = 6 per
group) were injected at the tail base with 200 μL of 1 mg mL−1 OVA
grade V, emulsiﬁed 1:1 with Complete Freund's Adjuvant (CFA;
Sigma) (immunization). Mice were daily orally (100 μL) treated with
PBS (CONTROL), dexamethasone (0.5 mg kg−1) or the tested amino al-
cohols (0.5 mg kg−1) during 6 days. After treatment period, their foot-
padswere injectedwith 30 μL of 20 mg mL−1 OVA grade II (challenge).
Animals were injected with an equal volume of phosphate-buffered
saline (PBS) into another footpad as a control. Forty-eight hours after
challenge, footpad thickness was measured with a pachymeter
(Starret). The magnitude of the DTH response was determined as
follows: [Paw edema (mm) or DTH units] = [footpad thickness of
OVA (mm)] − [footpad thickness of PBS (mm)].
2.9. Statistics
Results are representative of three independent experiments and
were presented as the mean ± SEM. The signiﬁcance of differences be-
tween groups was analyzed using a Student's t-test, Mann–Whitney
test, or two-way ANOVA (Graph Pad Prism 5.00) when appropriate.
The differences were considered signiﬁcant at p b 0.05.
3. Results
3.1. Compounds 4a, 4b and 9 reduced TNF-α production in vitro
Cell viability of RAW 264.7 or primary macrophages cultures were
evaluated by a MTT colorimetric assay for all compounds and none of
the compounds displayed changes in the viability of cell in the tested
concentrations (data not shown). In addition, all amino alcohols de-
creased the NO production (100% inhibition) in RAW 264.7 cultures,
however in primary macrophages the inhibition were not observed
(data not shown).
The supernatants of RAW 264.7 culture were analyzed for the quan-
tiﬁcation of TNF-α (Fig. 1A-F). The compounds 4a, 4b and 9 showed sig-
niﬁcant inhibitory effect on TNF-α production in the three highest
concentrations (Fig. 1A, B and E). Only the compound 6 not reduced
TNF-α production at least in the 1 μg mL−1 concentration (Fig. 1D). In
primary macrophages cultures were not observed inhibition of TNF-α
production after treatment (data not shown).3.2. Amino alcohols 4a and 4b reduced carrageenan-induced mice
paw edema
The amino alcohols 4a and 4b were chosen to be used as treatment
on carrageenan-induced mice paw edema due its better inhibition of
TNF-α in RAW264.7 cell cultures. Clinical signs of toxicity were not
observed immediately or during the post treatment period. Both com-
pounds showed effective reduction of paw edema of mice compared
to Carrageenan group who received only PBS treatment (Fig. 2A). The
amino alcohol 4b showed better reduction of edema, similar to dexa-
methasone (Fig. 2A).
After 4 h of induction of edema the paws were removed, weighed,
and the treatment with amino alcohol 4b showed potent reduction of
the pawsweight compared to Carrageenan group, similar to dexameth-
asone (Fig. 2B).
3.3. Compound 4b reduced IL-1β and TNF-α in macerate paws of mice after
carrageenan-induced edema
As shown in Fig. 2, the amino alcohol 4b showed signiﬁcant inhibito-
ry effect, compared to Carrageenan group, on the production of pro-
inﬂammatory cytokines IL-1β (Fig. 2C) and TNF-α (Fig. 2D) detected
in the supernatants of macerated paws of mice after 4 h of induction
of inﬂammatory edema by carrageenan.
3.4. Amino alcohols 4a and 4b reduced anti-OVA DTH
The amino alcohols 4a and 4b were chosen to be used as treatment
on delayed-type hypersensitivity mice paw edema. Both compounds
showed effective reduction of paw edema of mice compared to
CONTROL who received only PBS treatment (Fig. 3).
4. Discussion
The Inﬂammatory response is mainly regulated by nitric oxide (NO),
eicosanoids, and cytokines, all of which released by injured or infected
cells and have important roles in progression of inﬂammatory states
such as edema, intra/intercellular stress, and tissue necrosis [16].
The present study showed an immunomodulatory effect of the
amino alcohols tested in vitro and in vivo. In the RAW 264.7 cells, the li-
pophilic amino alcohols were not cytotoxic and showed inhibition of
nitric oxide (NO) and TNF-α. Moreover, in the carrageenan-induced
paw edemawere observed reduction of edema, with reduced detection
of IL-1β and TNF-α after treatment with compound 4b, which also re-
duced the edema in the DTH reaction, suggesting a down-regulation
of inﬂammatory mediators by lipophilic amino alcohols.
Previous studies already showed the capability of lipophilic amino
alcohols on the inhibition of NO production in J774 A.1 cell cultures
and the reduction of the inﬂammation in the delayed-type hypersensi-
tivity assay [11]. Moreover, lipophilic amino alcohols bearing a sugar
moiety showed inhibition of NO production and the authors suggested
a relation between the inhibition capacity and the lipophilic character-
istic of these compounds [9]. NO is an important mediator in acute in-
ﬂammation which is produced in pathophysiological conditions. At
the site of inﬂammation is produced by a number of different cells, in-
cluding leukocytes and endothelial cells [17].
TNF-α is a pro-inﬂammatory cytokine that stimulates phase reaction
in acute inﬂammation, with great diversity of biological activities in-
cluding inhibition of tumor growing and apoptosis induction [18]. In
the present study compounds 4a and 4b showed better reduction of
TNF-α production and were chosen to treating the carrageenan-
induced and DTH paw edema.
Carrageenan-induced mice paw edema is a widely used test to de-
termine the anti-inﬂammatory activity, and it has been fully character-
ized in the past showing acute inﬂammation by vasodilatation,
exudation of protein-rich ﬂuid (plasma) and cell migration, primarily
Fig. 1.TNF-αproduction by stimulated RAW264.7macrophages. RAW264.7 cellswere stimulatedwith 10 μg mL−1 of LPSplus 9 ng mL−1 IFN-γ, and cultured by24hs inpresence of serial
dilutions (1 μg mL−1 to 0.005 μg mL−1) of lipophilic amino alcohols: Compound 4a (A); Compound 4b (B); Compound 5 (C); Compound 6 (D); Compound 9 (E) and Compound 10 (F).
Supernatants were collected to determine TNF-α production. Each bar represents the arithmetic mean ± SEM. *p b 0.05, **p b 0.01 in comparison to stimulated and not treated cells
(RAW 264.7). Data are representative of three independent experiments.
730 E.F.C. Reis et al. / International Immunopharmacology 17 (2013) 727–732neutrophils, into the side of injury [19]. Mouse paw edema has been in-
creasingly used to test new anti-inﬂammatory drugs [17] and studies
showed that carrageenan injection causes the release of NO and induce
the release of TNF-α and IL-1β in the tissue [16]. In the present study,
the compound 4b showed effective reduction of the inﬂammation in
the paw edema with increased inhibition of TNF-α and IL-1β, which
were not observed by the treatment with compound 4a, suggesting a
better immunomodulatory effect of the compound 4b. Cytokines in-
volved in the inﬂammatory response, released by injured or infectedcells, that aremediators of carrageenan-induced inﬂammatory incapac-
itation, activate vascular endothelial cells and upregulate key adhesion
molecules that mediate tethering, rolling, cell adhesion, and extravasa-
tions of leucocytes. The leucocytes then migrate towards the site of
tissue inﬂammation [20].
The delayed-type hypersensitivity (DTH) reaction is also a useful ap-
proach for evaluating cell-mediated immune responses that migrates to
the inﬂammation site. The experimentalmodel of DTH toOVA allows an
assessment of the T-cell immune response. It also allows a simulation of
Fig. 2. Carrageenan-induced paw edema. Male BALB/c mice (n = 6 per group) were treated i.p. (100 μL) with PBS (Carrageenan group), the compounds 4a or 4b (0.5 mg kg−1) or dexa-
methasone (0.5 mg kg−1), 30 minutes before the induction of the carrageenan-induced paw edema. Paw edema [Paw edema (mm)] = [footpad thickness of carrageenan (mm)] −
[footpad thickness of PBS (mm)] were monitored until 4 hours (A). After 4 hours, mice were euthanized and the paws were removed and weighted (B). The paws were dissected, the
inﬂamed tissue macerated and the supernatants were analyzed to detect IL-1β (C) and TNF-α (D). Each bar represents the arithmetic mean ± SEM. *p b0.05 vs untreated group (Carra-
geenan). Data are representative of three independent experiments.
731E.F.C. Reis et al. / International Immunopharmacology 17 (2013) 727–732the course of certain autoimmune diseases [21]. In the present study,
the treatment with compounds 4a or 4b showed reduction of the
edema comparable to the observed with dexamethasone treatment.Fig. 3.Anti-OVADelayed-type hypersensitivity.Male BALB/cmice (n = 6per group)were
immunized with ovalbumin (OVA), daily treated i.p. (100 μL) with PBS (CONTROL), the
compounds 4a or 4b (0.5 mg kg−1) or dexamethasone (0.5 mg kg−1) and challenged
with aggregated OVA 6 days after the immunization. DTH was measured after 48 h of
the challenge. The magnitude of the DTH response was determined as follow: [Paw
edema (mm) or DTH units] = [footpad thickness of OVA (mm)] − [footpad thickness
of PBS (mm)]. Each bar represents the arithmetic mean ± SEM. *p b 0.05 compared to
untreated group (CONTROL). Data are representative of three independent experiments.Thereby, the compound 4b showed signiﬁcant anti-inﬂammatory
properties, both in vitro and in vivo, and further studies of themolecular
mechanisms are necessary to better explain its mechanism of action.
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